Guest Editor(s)
-
- Tommaso Trenti, MD
- Head of Department, Laboratory Medicine and Pathology, Azienda Ospedaliero-Universitaria Modena, Modena, Italy.
Website | E-mail
Special Issue Introduction
Laboratory Medicine plays a fundamental role in the first assessment of metabolic disorders as well as in the follow-up of these and the diagnosis and prognostication of target organ damage across all ages, from neonatal and pediatric ages to geriatrics and during pregnancy.
A wide range of techniques is available to this end, comprising point-of-care and self-administered tests; a routine evaluation of all classes of intermediate metabolism (glucose, lipids, urate, and proteins); genetics; epigenetics; metabolomics; characterization of gut microbiota. Laboratory tests are also essential in the diagnosis and prognostication of rare metabolic disorders in children and adults.
More recently, sophisticated information technology techniques such as big data analysis and artificial intelligence approaches promise to revolutionize public health administration by reducing expenses while enhancing accuracy in defining updated ranges of normality and putting together different databases, which may offer novel research opportunities.
With this evolving and intriguing scenario, it is pleased to announce a novel Special Issue on Metabolism and Target Organ Damage which is specifically dedicated to the role of Laboratory Medicine in Metabolic Disorders. Special importance will be given to innovative approaches and the laboratory assessment of cardiovascular risk and damage to target organs such as the liver, the kidneys, and others.
Submission Deadline
31 May 2023
Metabolism and Target Organ Damage
